Page 84 - Read Online

Raval et al. Vessel Plus 2024;8:5 https://dx.doi.org/10.20517/2574-1209.2023.99 Page 11 of 11

32. Faroux L, Guimaraes L, Wintzer-Wehekind J, et al. Coronary artery disease and transcatheter aortic valve replacement: JACC state-of-
the-art review. J Am Coll Cardiol 2019;74:362-72. DOI
33. Kotronias RA, Kwok CS, George S, et al. Transcatheter aortic valve implantation with or without percutaneous coronary artery
revascularization strategy: a systematic review and meta-analysis. J Am Heart Assoc 2017;6:e005960. DOI PubMed PMC
34. Lateef N, Khan MS, Deo SV, et al. Meta-analysis comparing outcomes in patients undergoing transcatheter aortic valve implantation
with versus without percutaneous coronary intervention. Am J Cardiol 2019;124:1757-64. DOI PubMed PMC
35. Maron DJ, Hochman JS, Reynolds HR, et al. Initial invasive or conservative strategy for stable coronary disease. N Engl J Med
2020;382:1395-407. DOI
36. Khawaja MZ, Wang D, Pocock S, Redwood SR, Thomas MR. The percutaneous coronary intervention prior to transcatheter aortic
valve implantation (ACTIVATION) trial: study protocol for a randomized controlled trial. Trials 2014;15:300. DOI PubMed PMC
37. Patterson T, Clayton T, Dodd M, et al. ACTIVATION (PercutAneous coronary inTervention prIor to transcatheter aortic VAlve
implantaTION): a randomized clinical trial. JACC Cardiovasc Interv 2021;14:1965-74. DOI
38. Witberg G, Regev E, Chen S, et al. The prognostic effects of coronary disease severity and completeness of revascularization on
mortality in patients undergoing transcatheter aortic valve replacement. JACC Cardiovasc Interv 2017;10:1428-35. DOI
39. Witberg G, Lavi I, Harari E, et al. Effect of coronary artery disease severity and revascularization completeness on 2-year clinical
outcomes in patients undergoing transcatether aortic valve replacement. Coron Artery Dis 2015;26:573-82. DOI
40. Biscaglia S, Guiducci V, Escaned J, et al. Complete or culprit-only PCI in older patients with myocardial infarction. N Engl J Med
2023;389:889-98. DOI
41. Doenst T, Haverich A, Serruys P, et al. PCI and CABG for treating stable coronary artery disease: JACC review topic of the week. J
Am Coll Cardiol 2019;73:964-76. DOI
42. Weferling M, Hamm CW, Kim WK. Percutaneous coronary intervention in transcatheter aortic valve implantation patients: overview
and practical management. Front Cardiovasc Med 2021;8:653768. DOI PubMed PMC
43. Lim Y, Tan KA, Kuntjoro I, Hon JK, Yip J, Tay E. Coronary artery disease in patients undergoing transvalvular aortic valve
implantation. Interv Cardiol 2022;17:e13. DOI PubMed PMC
44. van Rosendael PJ, van der Kley F, Kamperidis V, et al. Timing of staged percutaneous coronary intervention before transcatheter
aortic valve implantation. Am J Cardiol 2015;115:1726-32. DOI
45. Kotronias RA, Mamas MA, Bagur R. Revascularizing coronary artery disease in patients undergoing transcatheter aortic valve
implantation. J Thorac Dis 2018;10:E79-82. DOI PubMed PMC
46. Singh V, Rodriguez AP, Thakkar B, et al. Comparison of outcomes of transcatheter aortic valve replacement plus percutaneous
coronary intervention versus transcatheter aortic valve replacement alone in the United States. Am J Cardiol 2016;118:1698-704. DOI
47. Barbanti M, Todaro D, Costa G, et al. Optimized screening of coronary artery disease with invasive coronary angiography and Ad hoc
percutaneous coronary intervention during transcatheter aortic valve replacement. Circ Cardiovasc Interv 2017;10:e005234. DOI
48. Bao L, Gao Q, Chen S, et al. Feasibility and safety of combined percutaneous coronary intervention among high-risk patients with
severe aortic stenosis undergoing transcatheter aortic valve implantation: a systematic review and meta-analysis. Eur J Cardiothorac
Surg 2018;54:1052-9. DOI
49. Ochiai T, Yoon SH, Flint N, et al. Timing and outcomes of percutaneous coronary intervention in patients who underwent
transcatheter aortic valve implantation. Am J Cardiol 2020;125:1361-8. DOI
50. Rheude T, Costa G, Ribichini FL, et al. Comparison of different percutaneous revascularisation timing strategies in patients
undergoing transcatheter aortic valve implantation. EuroIntervention 2023;19:589-99. DOI
51. Tarantini G, Tang G, Nai Fovino L, et al. Management of coronary artery disease in patients undergoing transcatheter aortic valve
implantation. A clinical consensus statement from the European association of percutaneous cardiovascular interventions in
collaboration with the ESC working group on cardiovascular surgery. EuroIntervention 2023;19:37-52. DOI PubMed PMC
52. Khokhar AA, Ponticelli F, Zlahoda-Huzior A, et al. Coronary access following ACURATE neo implantation for transcatheter aortic
valve-in-valve implantation: ex vivo analysis in patient-specific anatomies. Front Cardiovasc Med 2022;9:902564. DOI PubMed
PMC